{"id":"W4406662629","doi":"10.1016/j.jid.2024.12.025","title":"Phase II Randomized Trial of BI 730357, an Oral RORγt Inhibitor, for Moderate-to-Severe Plaque Psoriasis","year":2025,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Boehringer Ingelheim","keywords":"Plaque psoriasis; Psoriasis; Dermatology; Medicine; Randomized controlled trial; RAR-related orphan receptor gamma; Pharmacology; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001519586,0.001972693,0.002788973,0.0003711927,0.0003648404,0.0009453282,0.0008785567,0.001314807,0.009807951],"category_scores_gemma":[0.001278704,0.0006144831,0.0009040698,0.0004009068,0.0007677953,0.000655364,0.0003521414,0.00220701,0.001706384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007087829,"about_ca_system_score_gemma":0.001673083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007443843,"about_ca_topic_score_gemma":0.001564883,"domain_scores_codex":[0.9994788,0.0002760083,0.00002860524,0.0000855028,0.00004184206,0.00008934813],"domain_scores_gemma":[0.9993845,0.0001129476,0.0001745451,0.00004678109,0.00004337881,0.0002377694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9640054,0.008419625,0.0004675103,0.0005132489,0.0004250286,0.00004705814,0.0000350033,0.0002701586,0.004369131,0.0001377968,0.001883851,0.01942618],"study_design_scores_gemma":[0.9608362,0.03728306,0.0007146246,0.0000169836,0.0001058483,0.00002767619,0.000006603997,0.0001901166,0.0002208792,0.00006371691,0.0005283066,0.000006136271],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9694245,0.006334265,0.00158382,0.001189612,0.000757113,0.01402453,0.00236839,0.0003870179,0.003930781],"genre_scores_gemma":[0.9597957,0.00429249,0.003355399,0.002386208,0.0007714377,0.01910125,0.002727619,0.00004932215,0.007520443],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009807951,"threshold_uncertainty_score":0.03281087,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0297421741863885,"score_gpt":0.3041298550137833,"score_spread":0.2743876808273948,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}